XML 61 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Reporting (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Segment Reporting [Abstract]    
Schedule of Business Interests Into Reportable Segments

The Company classifies its business interests into reportable segments which are Trxade, Community Specialty and Integra.

 

Nine Months Ended September 30, 2019   Trxade, Inc.     Community Specialty Pharmacy, LLC     Integra Pharma, LLC     Unallocated     Total  
Revenue   $ 3,335,050     $ 1,412,449     $ 992,862     $ -     $ 5,740,361  
Segment Assets   $ 1,561,760     $ 315,681       411,161     $ 3,565,921     $ 5,854,523  
Segment Profit/Loss   $ 1,748,896     $ (75,955 )   $ (122,144 )   $ (1,340,022 )   $ 210,775  

Year Ended December 31, 2018   Trxade, Inc.     Community Specialty Pharmacy, LLC     Other  
Revenue   $ 3,407,822     $ 395,418     $ 28,538  
Gross Profit   $ 3,407,822     $ (34,971 )   $ 9,878  
Segment Assets   $ 822,412     $ 112,123     $ 1,293,052  
Segment Profit/Loss   $ 1,371,615     $ (116,588 )   $ (1,245,989 )